The report compared infection rates for 2019 through 2022 for seven infections: Carbapenem-resistant Enterobacterales, Carbapenem-resistant Acinetobacter, Candida auris, Methicillin-resistant Staphylococcus aureus, Vancomycin-resistant Enterococcus, Extended-spectrum beta-lactamase and Multidrug-resistant Pseudomonas aeruginosa.
Of the seven infections, six have seen an increase over cases in 2019.
Comparing 2021 with 2022, five of the infections were stable and only C. auris increased. C. auris saw one of the most dramatic increases at nearly five-fold from 2019 to 2022.
Notably, Methicillin-resistant Staphylococcus aureus saw the only decrease in 2022 compared with 2021.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
